> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comment Period Extended on IRB Proposed Rules
- URL: https://www.fdaweb.com/comment-period-extended-on-irb-proposed-rules/
- Published: 2022-11-11T12:00:00.000Z
- Updated: 2026-09-14T18:06:11.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5153183

*Federal Register* notice: FDA is extending by two months the comment period on two proposed rules ([see earlier story](https://www.fdaweb.com/two-proposed-rules-modify-certain-irb-oversight/)) that appeared in the 9/28 *Federal Register*. One [proposed rule](https://public-inspection.federalregister.gov/2022-21089.pdf?ref=fdaweb.com) would replace current requirements for FDA-regulated cooperative research with new requirements that would require any institution located in the U.S. participating in such research to rely on review and approval by a single IRB for that portion of the research that is conducted in the U.S., with some exceptions. The other [proposed rule](https://public-inspection.federalregister.gov/2022-21088.pdf?ref=fdaweb.com) would amend FDA’s regulations to modernize, simplify, and enhance the current system for oversight of FDA-regulated human subject research. Comments can now be submitted until 12/28\. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-11-14/pdf/2022-24689.pdf?ref=fdaweb.com).